Skip to content
FindTrial
Search trials
Search trials by condition, treatment, sponsor...
Sign In
stereotactic radiation therapy (SRT)
RADIATION
2 trials
Sponsors
Istituto Clinico Humanitas
, Sue Yom
Conditions
Breast Cancer
Metastasis to Liver
Metastasis to Lung
Non Small Cell Lung Cancer
Phase 2
Pembrolizumab With and Without Radiotherapy for Non-Small Cell Lung Cancer
Completed
NCT03217071
Sue Yom
Non Small Cell Lung Cancer
Start: 2017-10-04
End: 2022-03-31
Updated: 2024-10-23
Unknown Phase
Study on SBRT for Inoperable Lung and Liver Oligometastases From Breast Cancer
NCT02581670
Istituto Clinico Humanitas
Breast Cancer, Metastasis to Liver, Metastasis to Lung
Start: 2015-11-04
End: 2023-10-31
Updated: 2022-05-04
Related Papers
Definitive results of a prospective non-randomized phase 2 study on stereotactic body radiation therapy (sbrt) for medically inoperable lung and liver oligometastases from breast cancer.
2024-03-22
4 citations
[Application of Neoadjuvant Immuno-chemotherapy in NSCLC].
2021-04-01
5 citations
Neoadjuvant anti-programmed Death-1 immunotherapy by Pembrolizumab in resectable nodal positive stage II/IIIa non-small-cell lung cancer (NSCLC): the NEOMUN trial.
2019-05-02
56 citations